NSCLC: Approach for Progression on Chemotherapy – OncLive
OncLive |
NSCLC: Approach for Progression on Chemotherapy
OncLive And now we have immunotherapy in the frontline setting, meaning that we will treat a second-line population that is different because one-third of the patients will receive immunotherapy frontline. And now in second-line therapy, we will enrich in PD … |
